REG - Polar Cap Glb Health PCGH ZDP PLC - Result of AGM

Polar Capital Global Healthcare TrustAnnouncement

13/02/2025 17:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250213:nRSM0756Xa&default-theme=true

RNS Number : 0756X  Polar Capital Global Health Tst PLC  13 February 2025

Polar Capital Global Healthcare Trust plc ("the Company")

Legal Entity Identifier: 549300YV7J2TWLE7PV84

 

Results of the Company's 14(th) Annual General Meeting ("AGM")

held at 2:00pm on Thursday 13 February 2025

 

All the resolutions proposed at the Annual General Meeting of the Company were
voted on and passed on a poll. The resolutions proposed at the AGM can be
found in the Notice of AGM which is available on the Company's website.

The following table indicates the number of poll votes received for each of
the resolutions. It should be noted that votes withheld do not
constitute votes in law. As at the date of the AGM, the Company's issued
share capital consisted of 124,149,256 Ordinary shares of 25p each. The
Company holds 2,879,256 Ordinary shares in treasury. Therefore, the total
voting rights in the Company is 121,270,000; 53% of the voting rights were
cast by proxy.

In accordance with Listing Rule 9.6.2, copies of resolutions 11 and 12 (having
been passed as special resolutions), will be submitted to the National Storage
Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

 Resolution                                                                     In favour   Against    Withheld
 1.    To receive and consider the Annual Report and Financial Statements       58,645,019  57,399     65,426
 for the year ended 30 September 2024.
 2.    To approve the Directors' Remuneration Implementation Report for the     58,526,075  164,985    76,784
 year ended 30 September 2024.

 3.    To Amend Article 98 in the company's Articles of Association.            58,508,223  174,078    85,543
 4.    To re-elect Lisa Arnold as a Director.                                   57,457,945  1,218,908  90,991

 5.    To re-elect Neal Ransome as a Director.                                  57,585,214  1,091,639  90,991

 6.    To re-elect Jeremy Whitley as a Director.                                57,586,835  1,084,930  96,079

 7.    To re-appoint PricewaterhouseCoopers LLP as auditors.                    58,570,791  106,739    90,314

 8.    To authorise the Directors to determine the auditors' remuneration.      58,616,576  65,427     85,841

 9.    To approve the Company's Dividend Policy.                                58,627,628  75,058     65,158

 10.  To authorise the allotment of ordinary shares.                            58,598,367  105,913    63,564

 11.  To disapply pre-emption rights.                                           58,474,848  194,016    98,980

 12.  To grant the Company authority to buy back its own ordinary shares.       58,652,187  68,143     47,514

 

 

Enquiries:

Tracey Lago, FCG

Polar Capital Global Healthcare Trust plc

020 7227 2700

https://www.polarcapitalglobalhealthcaretrust.co.uk/
(https://www.polarcapitalglobalhealthcaretrust.co.uk/)

 

13 February 2025

 

 

Neither the contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other website) is
incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSFDFMDEISEIE